we all have opinions,that's what makes a mkt. i'm long neph, biel, & one i believe is really coming on ldsr--(one i have not quite gotten my hands around as yet (more dd),but looking very good so far at $1.09 pps is crxx has fda pdufa date of 11/22 for "Exalgo"
BIEL has 720 million shares in its OS, NEPH has 37 million. You have to consider share count when it comes to possible market cap/company valuation. BIEL's products don't have any approvals yet, and their pricing for the products they do have are a bit high. People will spend $10 for a bottle of Tylenol or other cheap pain killers before spending $39 dollars on a throw away electrical patch. Until BIEL can find a way to reduce costs, they will only have a niche product.